|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
|
|---|---|---|
| Cash Flows From Operating Activities | ||
| Net income | ||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | ||
| Allowance for contract receivables | ||
| Stock based compensation | ||
| Allowance for accounts receivables | ||
| Bad debts written off during the year | ||
| Changes in operating assets and liabilities: | ||
| Accounts receivable | ||
| Contracts receivable | ||
| Inventories | ||
| Other current assets | ||
| Other assets | ||
| Accounts payable | ||
| Accrued expenses and other current liabilities | ||
| Deferred revenue | ||
| Other non current liabilities | ||
| Operating lease liability, net | ||
| Net cash used in operating activities | ||
| Cash Flows From Investing Activities | ||
| Purchase of equipment | ||
| Investment in Intangible | ||
| Net cash used in investing activities | ||
| Cash Flows From Financing Activities | ||
| Net repayment of debt | ||
| Proceeds from debt | ||
| Issuance of shares pursuant to initial public offering | ||
| Proceeds from issuance of common stock for cash | ||
| Net cash provided by (used in) financing activities | ||
| Effect of exchange rate changes on cash and cash equivalents | ||
| Net change in cash and cash equivalents | ||
| Cash and cash equivalents: | ||
| Beginning of the period | ||
| End of the period | ||
| Supplemental Disclosure of Cash Flow Information | ||
| Cash paid for interest | ||
| Supplemental Disclosure of Non-Cash Investing Activities and Financing Activities: | ||
| Right of use assets obtained in exchange of lease liabilities | ||
| Issuance of shares for purchase of non-controlling interest |
Loading...
